✦ LIBER ✦

The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia

✍ Scribed by Richel, DJ; Colly, LP; Kluin-Nelemans, JC; Willemze, R

Book ID: 109836596
Publisher: Nature Publishing Group
Year: 1991
Tongue: English
Weight: 823 KB
Volume: 64
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1991.258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the antileukaemic activity

Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia

✍ Richel, DJ; Colly, LP; Lurvink, E; Willemze, R 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 722 KB

Safety and clinical activity of 5-aza-2′

Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia

✍ Benton, Christopher B.; Thomas, Deborah A.; Yang, Hui; Ravandi, Farhad; Rytting, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

Cytotoxic activity of 2′,2′-difluorodeox

Cytotoxic activity of 2′,2′-difluorodeoxycytidine, 5-aza-2′-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene

✍ Christian M. Beauséjour; Jacynthe Gagnon; Mélanie Primeau; Richard L. Momparler 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Results of decitabine (5-aza-2′deoxycyti

Results of decitabine (5-aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

✍ Hagop M. Kantarjian; Susan O'Brien; Jorge Cortes; Francis J. Giles; Stefan Fader 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## BACKGROUND General and site‐specific DNA methylation is associated with tumor progression and resistance in several cancers, including chronic myelogenous leukemia (CML). Decitabine is a hypomethylating agent that has shown encouraging preliminary anti‐CML activity. This study evalu

MODULATION OF HLA-DR ANTIGENS EXPRESSION

MODULATION OF HLA-DR ANTIGENS EXPRESSION IN HUMAN MYELOID LEUKAEMIA CELLS BY CYTARABINE AND 5-AZA-2'-DEOXYCYTIDINE

✍ Pinto, Antonio; Maio, Michele; Attadia, Vincenza; Zappacosta, Serafino; Cimino, 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 434 KB

Phase 1/2 study of the combination of 5-

Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia

✍ Garcia-Manero, G.; Kantarjian, H. M.; Sanchez-Gonzalez, B.; Yang, H.; Rosner, G. 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 241 KB